NIH-funded research R21 grant

How a protein affects immune responses to bacterial infections

Official title: Modulation of neutrophil-endothelial interactions by ADAM10

Funded at Washington University · NIH-11039663 · Data updated 2026-11-12

This study is looking at how a protein called ADAM10 affects the way immune cells interact with blood vessel cells during infections caused by Staphylococcus aureus, with the hope of finding new ways to help the body fight these infections better.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startJanuary 23, 2025
Project endDecember 31, 2026
Funding year2025
Award (this year)$226,253
NIH project number1R21AI188434-01
Project IDNIH-11039663 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include both children and adults who are at risk of or suffering from Staphylococcus aureus infections.

Less likely to help

Patients with infections caused by other types of bacteria may not benefit from this research.

What this research studies

This research investigates how the protein ADAM10 influences the interactions between neutrophils and endothelial cells during Staphylococcus aureus infections. By understanding the mechanisms of how this protein modulates immune responses, the research aims to identify potential therapeutic targets that could enhance the body's ability to fight off these infections. The study will involve examining the effects of ADAM10 on immune cell behavior and its role in the injury caused by the bacteria. Patients may benefit from insights that could lead to improved treatments for infections caused by Staphylococcus aureus.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating serious bacterial infections.

How similar studies have gone: Previous research has shown promise in targeting similar mechanisms in bacterial infections, suggesting a potential for success in this approach.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Bubeck Wardenburg, Juliane — Washington University
  • Study coordinator: Bubeck Wardenburg, Juliane

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.